Literature DB >> 32030558

Knockdown of MCM10 Gene Impairs Glioblastoma Cell Proliferation, Migration and Invasion and the Implications for the Regulation of Tumorigenesis.

Peng Kang1,2,3, Zhe Han1, Zhiyi Liao1, Heng Zhang1, Wang Jia4,5, Yongji Tian6,7,8.   

Abstract

Minichromosome maintenance 10 (MCM10) plays an important role in DNA replication and is expressed in a variety of tumors, including glioma. However, its role and mechanism in glioma remain elusive. The purpose of this study was to examine the molecular function of MCM10 in glioblastoma cell lines in vitro and to further investigate the molecular mechanisms in the network mediated by MCM10. Cell proliferation, invasion, and migration were investigated in the absence of MCM10 mediated by RNA interference (RNAi) in U87 and U251 cell lines. Microarray data were obtained from U87 cells infected with a lentivirus expressing a small interfering RNA (siRNA) targeting MCM10, and ingenuity pathway analysis (IPA) was performed. Molecular signaling pathways, gene functions, and upstream and downstream regulatory genes and networks were analyzed. MCM10 was positively stained in human glioblastoma multiforme (GBM) samples according to immunohistochemistry. Silencing MCM10 in U87 and U251 cells significantly reduced cell proliferation, migration, and invasion. In U87 cells transfected with MCM10, 274 genes were significantly upregulated, while 313 genes were downregulated. IPA revealed that MCM10 is involved in the IGF-1 signaling pathway, and calcitriol appears to be a significant upstream regulator of MCM10. Other factors, such as TWIST1 and Stat3, also interact within the MCM10-mediated network. Our data indicate that MCM10 is involved in the regulation of GBM in vitro and may provide more evidence for understanding the molecular mechanisms of this fatal disease.

Entities:  

Keywords:  Glioma; IPA; MCM10; Migration; Proliferation

Year:  2020        PMID: 32030558     DOI: 10.1007/s12031-020-01486-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  35 in total

1.  Overexpression of minichromosome maintenance protein 10 in medulloblastoma and its clinical implications.

Authors:  Daniel Senfter; Erdogan Pekcan Erkan; Erdener Özer; Gerhard Jungwirth; Sibylle Madlener; Marcel Kool; Thomas Ströbel; Nurten Saydam; Okay Saydam
Journal:  Pediatr Blood Cancer       Date:  2017-06-09       Impact factor: 3.167

2.  A network-based analysis of systemic inflammation in humans.

Authors:  Steve E Calvano; Wenzhong Xiao; Daniel R Richards; Ramon M Felciano; Henry V Baker; Raymond J Cho; Richard O Chen; Bernard H Brownstein; J Perren Cobb; S Kevin Tschoeke; Carol Miller-Graziano; Lyle L Moldawer; Michael N Mindrinos; Ronald W Davis; Ronald G Tompkins; Stephen F Lowry
Journal:  Nature       Date:  2005-08-31       Impact factor: 49.962

3.  Targeted disruption of Mcm10 causes defective embryonic cell proliferation and early embryo lethality.

Authors:  Han Jeong Lim; Yoon Jeon; Chang Hwan Jeon; Jong Hyun Kim; Ho Lee
Journal:  Biochim Biophys Acta       Date:  2011-06-15

4.  Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.

Authors:  Ariane Söling; Mirko Sackewitz; Michael Volkmar; Daniel Schaarschmidt; Roland Jacob; Hans-Jürgen Holzhausen; Nikolai G Rainov
Journal:  Clin Cancer Res       Date:  2005-01-01       Impact factor: 12.531

5.  MCM10 facilitates the invaded/migrated potentials of breast cancer cells via Wnt/β-catenin signaling and is positively interlinked with poor prognosis in breast carcinoma.

Authors:  Wei-Dong Yang; Lu Wang
Journal:  J Biochem Mol Toxicol       Date:  2019-04-16       Impact factor: 3.642

6.  MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.

Authors:  N Ramnath; F J Hernandez; D F Tan; J A Huberman; N Natarajan; A F Beck; A Hyland; I T Todorov; J S Brooks; G Bepler
Journal:  J Clin Oncol       Date:  2001-11-15       Impact factor: 44.544

7.  The Mcm2-7-interacting domain of human mini-chromosome maintenance 10 (Mcm10) protein is important for stable chromatin association and origin firing.

Authors:  Masako Izumi; Takeshi Mizuno; Ken-Ichiro Yanagi; Kazuto Sugimura; Katsuzumi Okumura; Naoko Imamoto; Tomoko Abe; Fumio Hanaoka
Journal:  J Biol Chem       Date:  2017-06-22       Impact factor: 5.157

8.  MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.

Authors:  Wei-Ming Li; Chun-Nung Huang; Hung-Lung Ke; Ching-Chia Li; Yu-Ching Wei; Hsin-Chih Yeh; Lin-Li Chang; Chun-Hsiung Huang; Peir-In Liang; Bi-Wen Yeh; Ti-Chun Chan; Chien-Feng Li; Wen-Jeng Wu
Journal:  Oncotarget       Date:  2016-11-22

9.  DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer.

Authors:  Ravikiran Mahadevappa; Henrique Neves; Shun Ming Yuen; Muhammad Jameel; Yuchen Bai; Hiu-Fung Yuen; Shu-Dong Zhang; Youzhi Zhu; Yao Lin; Hang Fai Kwok
Journal:  Cancers (Basel)       Date:  2018-08-22       Impact factor: 6.639

10.  Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis.

Authors:  Mitali Das; Shyam Babu Prasad; Suresh Singh Yadav; H B Govardhan; Lakshmi Kant Pandey; Sunita Singh; Satyajit Pradhan; Gopeshwar Narayan
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

View more
  3 in total

1.  MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer.

Authors:  Zhenzhen Wu; Yueyuan Wang; Juan Li; Huiling Wang; Xunyuan Tuo; Jing Zheng
Journal:  Front Genet       Date:  2022-05-19       Impact factor: 4.772

2.  Integrative Analysis of Minichromosome Maintenance Proteins and Their Prognostic Significance in Melanoma.

Authors:  Wei Han; Yi-Zhu Wu; Xiao-Yu Zhao; Zhen-Hua Gong; Guo-Liang Shen
Journal:  Front Oncol       Date:  2021-08-19       Impact factor: 6.244

3.  Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution.

Authors:  Lixian Chang; Zejia Cui; Deyang Shi; Yajing Chu; Bichen Wang; Yang Wan; Qiuyi Ma; Ranran Zhang; Haoyuan Li; Xuelian Cheng; Tao Cheng; Xiaofan Zhu; Cheng Li; Weiping Yuan
Journal:  Exp Hematol Oncol       Date:  2022-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.